A Biomimetic Nanoparticle System Intercepts and Degrades Thrombospondin‐1 to Restore Vascular Homeostasis After Ischemic Injury
Advanced Science · 2026-07 · 13 (38)
DOI: 10.1002/advs.75344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.04.2026. Verfasst von Haorui Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, The First Hospital, Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Thrombospondin 1, Nanoparticles, Reperfusion Injury, Liver. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Jilin University (China)..
Abstract (Originalsprache)
The thrombospondin‐1 (TSP‐1)/CD47 signaling axis plays a critical role in endothelial injury during hepatic ischemia‐reperfusion (IR). Targeting this pathway represents a promising strategy to prevent liver IR injury; however, existing CD47 antagonists cause severe hematologic side effects due to nonspecific binding to erythrocytes. This study developed TAX2 (CD47‐derived peptide with the sequence CEVSQLLKGDAC)‐functionalized biodegradable nanoparticles (TAX2‐NPs) that specifically capture TSP‐1 and block its interaction with CD47 on liver sinusoidal endothelial cells (LSECs). TAX2‐NPs are composed of PLGA and DSPE‐PEG‐Mal and are conjugated with the cyclic peptide TAX2, derived from the TSP‐1‐binding domain of CD47. Upon systemic administration, TAX2‐NPs preferentially accumulate in the injured liver, where they competitively bind TSP‐1, preventing endothelial apoptosis and preserving sinusoidal integrity. Captured TSP‐1 is subsequently internalized by macrophages and degraded via the autophagy‐lysosome pathway, thereby eliminating residual extracellular TSP‐1 and mitigating its prolonged pathogenic effects. Collectively, this study presents a ligand‐targeted nanotherapeutic strategy that integrates TSP‐1 sequestration, signaling blockade, and autophagy‐mediated degradation, offering a safe and effective approach to protect the liver from ischemia‐reperfusion injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, The First Hospital, Jilin University, Changchun, Jilin, China.
- National-local Joint Engineering Laboratory of Animal Models For Human Diseases, Changchun, Jilin, China.
- International Center of Future Science, Jilin University, Changchun, Jilin, China.
- State Key Laboratory of Kidney Diseases, Beijing, China.
- State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, Jilin, China.
ORCID-Profile: Yong-Guang Yang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities, Jilin University (China).
Zitieren
APA
Wang, H., Meng, X., Xin, Y., Mao, K., Tan, H., Ma, C., Cong, X., Zhao, M., Yu, M., Chen, S., Hou, Y., Yang, Y. G., & Sun, T. (2026). A Biomimetic Nanoparticle System Intercepts and Degrades Thrombospondin‐1 to Restore Vascular Homeostasis After Ischemic Injury. Advanced Science, 13(38). https://doi.org/10.1002/advs.75344
Vancouver
Wang H, Meng X, Xin Y, Mao K, Tan H, Ma C, et al. A Biomimetic Nanoparticle System Intercepts and Degrades Thrombospondin‐1 to Restore Vascular Homeostasis After Ischemic Injury. Advanced Science. 2026;13(38). doi:10.1002/advs.75344
BibTeX
@article{Wang2026,
author = {Wang, Haorui and Meng, Xiandi and Xin, Yanbao and Mao, Kuirong and Tan, Huizhu and Ma, Changkai and Cong, Xiuxiu and Zhao, Mengfei and Yu, Meiling and Chen, Si and Hou, Yue and Yang, Yong-Guang and Sun, Tianmeng},
title = {A Biomimetic Nanoparticle System Intercepts and Degrades Thrombospondin‐1 to Restore Vascular Homeostasis After Ischemic Injury},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {38},
doi = {10.1002/advs.75344}
}
EUVIMED